CID 53362096
Sovaprevir
Structural Information
- Molecular Formula
- C43H53N5O8S
- SMILES
- CC(C)(C)[C@H](CC(=O)N1CCCCC1)C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=CC(=NC6=C5C=CC(=C6)OC)C7=CC=CC=C7
- InChI
- InChI=1S/C43H53N5O8S/c1-6-28-25-43(28,41(52)46-57(53,54)31-16-17-31)45-39(50)36-22-30(26-48(36)40(51)33(42(2,3)4)23-38(49)47-19-11-8-12-20-47)56-37-24-34(27-13-9-7-10-14-27)44-35-21-29(55-5)15-18-32(35)37/h6-7,9-10,13-15,18,21,24,28,30-31,33,36H,1,8,11-12,16-17,19-20,22-23,25-26H2,2-5H3,(H,45,50)(H,46,52)/t28-,30-,33-,36+,43-/m1/s1
- InChIKey
- MHFMTUBUVQZIRE-WINRQGAFSA-N
- Compound name
- (2S,4R)-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 800.36878 | 233.0 |
[M+Na]+ | 822.35072 | 240.9 |
[M+NH4]+ | 817.39532 | 236.2 |
[M+K]+ | 838.32466 | 240.5 |
[M-H]- | 798.35422 | 248.7 |
[M+Na-2H]- | 820.33617 | 243.8 |
[M]+ | 799.36095 | 240.6 |
[M]- | 799.36205 | 240.6 |